Bone Density Changes during Adjuvant Aromatase Inhibitor Treatment in Breast Cancer Patients: Single Centre Experience

机译：乳腺癌患者辅助芳香化酶抑制剂治疗期间的骨密度变化：单中心经验。

获取原文

页面导航

摘要
著录项
相似文献
相关主题

摘要

I. BackgroundAdjuvant aromatase inhibitors (Al) therapy in breast cancer accelerates bone loss resulting in increased incidence of fracture. We evaluated the effect of AI on bone density changes among breast cancer patients in our cancer centre.

机译：一，背景乳腺癌的辅助芳香化酶抑制剂（Al）治疗会加速骨质流失，导致骨折发生率增加。我们在癌症中心评估了AI对乳腺癌患者骨密度变化的影响。

著录项

来源
《World congress on medical physics and biomedical engineering;International congress of the IUPESM》|2011年|p.930|共1页
会议地点
作者

展开▼
作者单位

展开▼
会议组织
原文格式 PDF
正文语种
中图分类医用物理学;
关键词

相似文献

外文文献
中文文献
专利

1. Phase 2 placebo-controlled, single-blind trial to evaluate the impact of oral ibandronate on bone mineral density in osteopenic breast cancer patients receiving adjuvant aromatase inhibitors: 5-year results of the single-centre BONADIUV trial [J] . Livi Lorenzo, Scotti Vieri, Desideri Isacco, European journal of cancer: official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR) . 2019,第期

机译：第2阶段安慰剂控制，单盲试验，评估口服IBandronate对接受佐剂芳香酶抑制剂的骨乳腺癌患者骨密度的影响：单中心Bonadiuv试验的5年结果
2. Managing bone health in women with breast cancer under adjuvant treatment with aromatase inhibitors: pretreatment bone mineral density is important [J] . Christos Markopoulos Breast Cancer Research . 2010,第4期

机译：在芳香化酶抑制剂辅助治疗下控制乳腺癌女性的骨骼健康：预处理骨矿物质密度很重要
3. Changes in bone mineral density after adjuvant aromatase inhibitors and fracture risk in breast cancer patients. Clinical Oncology [J] . Berruti A, Tucci M, Mosca A, Journal of Clinical Oncology . 2007,第11期

机译：辅助芳香酶抑制剂后的骨矿物质密度变化和乳腺癌患者的骨折风险。临床肿瘤学
4. Bone Density Changes during Adjuvant Aromatase Inhibitor Treatment in Breast Cancer Patients: Single Centre Experience [C] . (missing) World congress on medical physics and biomedical engineering . 2009

机译：乳腺癌患者辅助芳香酶抑制剂治疗期间的骨密度变化：单一中心经验
5. Musculoskeletal symptoms in women on aromatase inhibitors for adjuvant breast cancer therapy. [D] . Olufade, Temitope. 2012

机译：妇女在芳香酶抑制剂上的肌肉骨骼症状可用于辅助性乳腺癌治疗。
6. Managing bone health in women with breast cancer under adjuvant treatment with aromatase inhibitors: pretreatment bone mineral density is important [O] . Christos Markopoulos 2010

机译：在芳香酶抑制剂辅助治疗下控制乳腺癌女性的骨骼健康：预处理骨矿物质密度很重要
7. Managing bone health in women with breast cancer under adjuvant treatment with aromatase inhibitors: pretreatment bone mineral density is important [O] . Markopoulos, Christos 2010

机译：在芳香酶抑制剂辅助治疗下控制乳腺癌女性的骨骼健康：预处理骨矿物质密度很重要

Bone Density Changes during Adjuvant Aromatase Inhibitor Treatment in Breast Cancer Patients: Single Centre Experience

摘要

著录项

相似文献

相关主题

期刊订阅